Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-14-018776)

Filing Details

Accession Number:: 0001127602-14-018776
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-23 17:12:56
Reporting Period:: 2014-05-22

Filing Date:: 2014-05-23
Accepted Time:: 2014-05-23 17:12:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376548	Elliot Ehrich	852 Winter St. Waltham MA 02451	Svp, R&D & Cmo, Alkermes, Inc.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2014-05-22	2,378	$44.49	20,992	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.17 to $44.7701. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.